Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Naka

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive ratsY Inada, T Wada, Y Shibouta, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)Y Shibouta, Y Inada, M Ojima, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient miceT Naka, T Matsumoto, M Narazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient miceH Fujiwara, H Kikutani, S Suematsu, et al.
Nihon Naibunpi Gakkai Zasshi|March 20, 1980
[The long term effect of the oral converting enzyme inhibitor captopril in hypertensive patients (author's transl)]T Ogihara, A Maruyama, T Naka, et al.
Cell Death & Disease|July 6, 2013
ifn-γ-dependent secretion of IL-10 from Th1 cells and microglia/macrophages contributes to functional recovery after spinal cord injuryH Ishii, S Tanabe, M Ueno, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 19, 2013
Characteristics of a granular electronic system in Heusler-type Fe2+xV1-xAlT Naka, K Sato, M Taguchi, et al.
Biochemical Pharmacology|July 20, 1993
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistM Noda, Y Shibouta, Y Inada, et al.
The International Journal of Artificial Organs|January 13, 2006
A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltrationM Egi, T Naka, R Bellomo, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 10, 1982
[The variation in the blood pressure of the patients with essential hypertension in summer and winter (author's transl)]T Hata, T Ogihara, A Maruyama, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1994
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive ratsY Inada, T Wada, Y Shibouta, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)Y Shibouta, Y Inada, M Ojima, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 1998
Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient miceT Naka, T Matsumoto, M Narazaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 1994
The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient miceH Fujiwara, H Kikutani, S Suematsu, et al.
Nihon Naibunpi Gakkai Zasshi|March 20, 1980
[The long term effect of the oral converting enzyme inhibitor captopril in hypertensive patients (author's transl)]T Ogihara, A Maruyama, T Naka, et al.
Cell Death & Disease|July 6, 2013
ifn-γ-dependent secretion of IL-10 from Th1 cells and microglia/macrophages contributes to functional recovery after spinal cord injuryH Ishii, S Tanabe, M Ueno, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 19, 2013
Characteristics of a granular electronic system in Heusler-type Fe2+xV1-xAlT Naka, K Sato, M Taguchi, et al.
Biochemical Pharmacology|July 20, 1993
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistM Noda, Y Shibouta, Y Inada, et al.
The International Journal of Artificial Organs|January 13, 2006
A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltrationM Egi, T Naka, R Bellomo, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 10, 1982
[The variation in the blood pressure of the patients with essential hypertension in summer and winter (author's transl)]T Hata, T Ogihara, A Maruyama, et al.
Pageof 14